Patent details
EP2292617 Title: 1,3-dihydro-imidazoÖ4,5-cÜquinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors
Basic Information
- Publication number:
- EP2292617
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101753697
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 1,3-dihydro-imidazoÖ4,5-cÜquinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors
- French Title of Invention:
- Dérivés de 1,3-dihydro-imidazoÖ4,5-cÜquinolin-2-one comme inhibiteurs de kinase lipidique et/ou de kinase pi3
- German Title of Invention:
- 1,3-dihydro-imidazoÖ4,5-cÜquinolin-2-on-Verbindungen als Lipidkinase und/oder pi3 Kinase Hemmer
- SPC Number:
Dates
- Filing date:
- 18/05/2006
- Grant date:
- 11/07/2012
- EP Publication Date:
- 11/07/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/03/2011
- EP B1 Publication Date:
- 11/07/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/05/2013
- Expiration date:
- 18/05/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 18/05/2006
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- Stauffer Frédéric
- Address:
- Switzerland (CH)
2
- Name:
- Furet Pascal
- Address:
- France (FR)
3
- Name:
- Garcia-Echeverria Carlos
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 0510390
- Priority Date:
- 20/05/2005
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- C07D 471/04;
| Filing date | Document type | Number of pages |
|---|